HOME >> BIOLOGY >> NEWS
'Meeting of the minds' leads new era in fight against cancer

Orlando, Fla. Leading researchers are gathering today for the 95th Annual Meeting of the American Association for Cancer Research (AACR), the premier multidisciplinary assembly, which features the latest developments in basic, prevention, translational and clinical cancer research. The meeting occurs from March 27 31, 2004 at the Orlando Convention Center, Fla.

"Because scientific advances are pushing forward at such an incredible pace, our insight into cancer mechanism and progression is growing exponentially," said Karen Antman, M.D., president of AACR. "The AACR Annual Meeting will help us harness this information to develop and discover cutting-edge diagnostics and treatments necessary to conquer this disease."

This year's Annual Meeting will spotlight new information and innovations that are leading to a new understanding of cancer and its course of action. Presentations by top scientists will include novel technologies and research approaches, lifesaving therapies in the pipeline, and new insights into prevention.

"Thanks to persistence and determination on part of the researchers, we can better understand the intricacies of cancer that will ultimately lead to its cure," said Dr. Antman.

The discussions presented during the opening plenary session, Targeting the Conquest of Cancer through Conceptual Integration and Innovation (Sunday, March 28, 9:30 a.m. to 12:00 p.m.), reflect the theme of this year's Annual Meeting Information Integration for Innovation.

Researchers will present a broad range of discoveries in the field of cancer research, including an in-depth review of telomerase, a DNA shield which may be central to cancer progression, followed by a continued investigation into the impact of COX-2. The increasingly important area of genomics also will be highlighted by researchers who will discuss the identification of undiscovered gene functions as potential targets for the development of anti-cancer dr
'"/>

Contact: Aimee Frank
amf@spectrumscience.com
202-955-6222
American Association for Cancer Research
27-Mar-2004


Page: 1 2

Related biology news :

1. Loss of the neuronal adhesion protein d-catenin leads to severe cognitive dysfunction
2. Cockroach-like robot leads new research effort
3. Washington University in St. Louis leads group studying aging process
4. Green tea research leads to gum and other products
5. Cancer drug resistance research leads to possible therapeutic target for Alzheimers disease
6. Research into cetacean reproduction leads to birth of killer whales by artificial insemination
7. UCSD finds genetic time bomb in heart that leads to heart failure in some patients
8. Delirium high in ICU patients, leads to death, morbidity
9. Gene mutation leads to super-virulent strain of TB
10. Researchers show absence of key oxygen-sensing molecule leads to developmental defects
11. Ten-year study leads researchers to psoriasis genes

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Meeting the minds leads new era fight against cancer

(Date:8/11/2015)... August 11, 2015 Today, ZUK announced its ... as well as expected revenues in 2015 that relate to sales ... revenue guidance of approximately 2,200 MSEK for 2015. Jörgen ... prominent smartphone manufacturer in China ... selected FPC1 155 for Z1 ...
(Date:8/6/2015)... Germany , August 6, 2015 ... (SMI) shows the world,s first Eye Tracking ... Epson,s Moverio BT-200 see-through head mounted display and on ... unprecedented quality and efficiency is brought to personalized visualization ... the first time, professionals and researchers can integrate gaze, ...
(Date:8/5/2015)... , Aug. 5, 2015 The biosensors market ... in applications, penetration into newer sectors, and development of ... global biosensors space has seen the entry of multiple ... so far. (Photo - http://photos.prnewswire.com/prnh/20150805/255570 ) ... Analysis of the Global Biosensors Market ( ...
Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4
(Date:8/31/2015)... , Aug. 31, 2015  For people with Down ... their day. The biotechnology company, located in the Science ... of the best potential therapies yet for people with Down ... " Correction of Down syndrome and Edwards syndrome aneuploidies ... DNA Research . Elixirgen plans to develop this ...
(Date:8/31/2015)... 31, 2015 FLX Bio, Inc., a biopharmaceutical ... cancer immunotherapies, announced today that it has appointed ... and William Ho , M.D., Ph.D., as Chief ... management team led by veterans of Flexus Biosciences, Inc., ... Scientific Officer; Jay Powers , Ph.D., Vice President, ...
(Date:8/31/2015)... ... August 31, 2015 , ... There’s a new treatment option for excessive menstrual ... available new FDA approved system in the last 14 years, and the only endometrial ... (zero bleeding) rate of 66%, the high Patient Satisfaction rate of 98%, and the ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... presented two studies at the International Spine Intervention Society’ s 23rd ... through to August 1st, 2015. With a focus on evidence-based research and clinical ...
Breaking Biology Technology:New Down syndrome therapy discovered 2FLX Bio Announces Senior Management Hires and Initiation of Phase 1 Trial of FLX925 2FLX Bio Announces Senior Management Hires and Initiation of Phase 1 Trial of FLX925 3FLX Bio Announces Senior Management Hires and Initiation of Phase 1 Trial of FLX925 4U.S. FDA Approves Minerva Endometrial Ablation System 2U.S. FDA Approves Minerva Endometrial Ablation System 3Proove Biosciences Presents New Research Study at the International Spine Intervention Society’s Annual Scientific Meeting 2Proove Biosciences Presents New Research Study at the International Spine Intervention Society’s Annual Scientific Meeting 3Proove Biosciences Presents New Research Study at the International Spine Intervention Society’s Annual Scientific Meeting 4
Cached News: